Dr. Griffin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Avenue
Dana-Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3360Fax+1 617-632-2260
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1979 - 1980
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1976 - 1977
- Johns Hopkins UniversityResidency, Internal Medicine, 1974 - 1976
- Harvard Medical SchoolClass of 1974
Certifications & Licensure
- MA State Medical License 1975 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1989
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 293 citationsThe JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic ...Ross L. Levine, Marc M. Loriaux, Brian J. P. Huntly, Mignon L. Loh, M. Beran
Blood. 2005-11-15 - 2286 citationsActivating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.Ross L. Levine, Martha Wadleigh, Jan Cools, Benjamin L. Ebert, Gerlinde Wernig
Cancer Cell. 2005-04-01 - 75 citationsThe biology of GM-CSF: regulation of production and interaction with its receptor.James D. Griffin, Stephen A. Cannistra, George D. Demetri, T J Ernst, Yuzuru Kanakura
International Journal of Cell Cloning. 1990-01-01
Press Mentions
- 'World First' For Double Hand Transplant PatientMay 10th, 2024
- RXi Pharmaceuticals Appoints Medical Oncology Expert, Dr. James Griffin, to Scientific Advisory BoardApril 25th, 2017
- TFS Appoints Dr. Bassem Saleh as Chief Medical Officer and Mr. Edward (Ed) Tumaian as VP Global Clinical DevelopmentMarch 22nd, 2017
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: